Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published August 2021 | Version v1.0.0
Journal Article Open

Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound

Abstract

Many survivors from severe coronavirus disease 2019 (COVID-19) suffer from persistent dyspnea and fatigue long after resolution of the active infection. In a cohort of 21 consecutive severe post-COVID-19 survivors admitted to an inpatient rehabilitation hospital, 16 (76%) of them had at least one sonographic abnormality of diaphragm muscle structure or function. This corresponded to a significant reduction in diaphragm muscle contractility as represented by thickening ratio (muscle thickness at maximal inspiration/end-expiration) for the post-COVID-19 compared to non-COVID-19 cohorts. These findings may shed new light on neuromuscular respiratory dysfunction as a contributor to prolonged functional impairments after hospitalization for post-COVID-19.

Other

original_citation: Farr E, Wolfe AR, Deshmukh S, Rydberg L, Soriano R, Walter JM, Boon AJ, Wolfe LF, Franz CK. Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound. Annals of Clinical and Translational Neurology. 2021;8(8):1745-1749.

Files

Ann Clin Transl Neurol - 2021 - Farr - Diaphragm dysfunction in severe COVID19 as determined by neuromuscular ultrasound.pdf

Additional details

Created:
March 30, 2023
Modified:
March 20, 2024